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Glial tumours are the most common primary tumours in the human central nervous system. These neoplasms form a heterogeneous group, composed of several histological subtypes, with different degrees of malignancy. Glioblastoma multiforme and high-grade astrocytomas represent more than half the cases (James et al., 1988; Yung et al., 1989; Venter & Thomas, 1991) . Despite many attempts to characterise these tumours by biochemical, cytogenetic, immunochemical and molecular approaches, progress in therapy is limited and the prognosis for patients remains poor.
Cytogenetic analyses have been extensively performed on human gliomas (Rey et al., 1983 (Rey et al., , 1987a Bigner et al., 1986 Bigner et al., , 1988 Bigner et al., , 1990 Heim et al., 1989; Jenkins et al., 1989; Thiel et al., 1992) . In tumours of low malignancy, the karyotype is frequently normal or may exhibit a loss of sex chromosome and a gain of chromosome 7. These two abnormalities, being observed in normal cells in culture (Rey et al., 1987a; Heim et al., 1*69; Thiel et al., 1992) , may not necessarily characterise a malignant condition. Hence, no specific chromosomal anomaly may occur in such tumours. In highly malignant tumours, by contrast, karyotypes tend to become polyploid with an accumulation of anomalies, among which gain of chromosome 7 and loss of chromosome 10 are the most frequent. Other abnormalities, such as losses or deletions of chromosomes 9, 22, 6, 13 and 14 or gains of chromosomes 19 and 20, may be observed also, but less frequently (Rey et al., 1987b; Bigner et al., 1988 Bigner et al., , 1990 Jenkins et al., 1989) . In addition, a large proportion of highly malignant gliomas have double minute chromosomes (Bigner et al., 1986 (Bigner et al., , 1990 Thiel et al., 1992) .
We postulate that these recurrent chromosomal imbalances could be related to metabolic disturbances, as in human colorectal adenocarcinomas, in which activities of de and salvage pathways for pyrimidine synthesis have been related to cytogenetic anomalies (Luccioni et al., 1988; Bardot et al., 1991; Bravard et al., 1991) . In brain tumours, cytogenetic anomalies (especially losses) tend to involve chromosomes carrying genes encoding enzymes of adenine metabolism: AKI and AX2 (adenylate kinase) and MTAP (methylthioadenosine phosphorylase) on chromosome 9, ADK (adenosine kinase) and A TPase (ATP synthetase mitochondrial) on chromosome 10, ADSL (adenylosuccinate lyase) on chromosome 22, NP (purine nucleoside phosphorylase) on chromosome 14 and ADA (adenosine deaminase) on chromosome 20 (HMG 10, 1989 (EC 3.5.4.4) and AMPD (adenosine monophosphate deaminase, EC 3.5.4.6). The relationship of these enzymes in the general pathway of purine metabolism is shown in Figure 1 . In parallel, two enzymes involved in pyrimidine synthesis, TK (thymidine kinase, EC 2.7.1.21) and TS (thymidylate synthase, EC 2.1.1.45), were studied.
Since tumours grafted in nude mice are widely used and represent an interesting source of partially purified tumour tissue, we also studied six human gliomas growing as nude mouse xenografts. 
Materiasd and methods

Chemicals
Preparation of homogenates
Samples were homogenised in Tris-HCl buffer 50 mM, sucrose 250 mM, Triton X-100 0.1%, pH 7.5 (1/1, w/v). Homogenates were then centrifuged at 20,000 g for 1 h and supernatants were stored as aliquots at -80-C for all further enzymatic measurements.
Enzyme assays Purine metabolism, including the ten enzymes studied, is depicted schematically in Figure 1 . The activities of ADK, APRT, AK, HPRT, ADSL, ADA, NP and AMPD were determined according to methods to be described elsewhere.
MTAP activity was determined by measuring the formation of adenine from [8-'4Cmethylthioadenosine, according to a method described by Kamatani and Carson (1980) . The final concentrations of the reaction mixture were 100mM phosphate buffer, pH 7.4, 35 mM potassium hydrogen phosphate, 0.05 mM [8-'4CJ5'-deoxy-5'-methylthioadenosine (4.6 Ci mol-'). The reaction mixture was incubated for 45 min at 37C and the reaction stopped by heating at 100lC for 2 min.
Samples were then centrifuged at 15,000 g for 20 min, before quantification of products and substrates by a highperformance liquid chromatographic (HPLC) method. The separation was effected on a reversed-phase silica column, Cl, Novapak (Waters). The mobie phase was composed of 15.5% methanol and 2% 500mM phosphate buffer with an apparent pH of 6. The isocratic elution was run at a flow rate of 1 mlmin'-. TK activity (total activity) was determined by a radiochemical assay (Bardot et al., 1991) . TS activity was determined by measuring the formation of tritiated water from [5-3H]dUMP (Bardot et al., 1991) .
For each enzyme assay, linearity with time and protein content was verified. Liver extracts from newborn rats were run in parallel as standard and all values were read against a blank without cellular extract. All assays were performed in duplicate and results were normalised to the protein content for each sample. Protein content was estimated using a BioRad kit (Richmond, CA, USA) with albumin as standard. All enzymatic assays were adapted from previously published methods, to use microquantities of tumour samples.
The Mann-Whitney U-test was used for comparing the different groups of samples: primary tumours versus normal brain tissue, tumours of low grade versus tumours of high grade and grafted tumours versus the corresponding primary tumours.
Cytogenetic studies For direct karyotyping, fresh human tumours were minced with scissors and seeded into medium F12 (Gibco) containing 20% fetal calf serum and epidermal growth factor (Sigma) (0.03 mg I'). Metaphases were obtained after 1-3 weeks' culture.
Athymic 5-week-old female nude mice (nu/nu, Swiss genetic background) were transplanted with pieces of approximately 3 mm in diameter into the right flanks. Between 1 and 4 animals were transplanted with each tumour, and further passages were performed in the same way in 4-5 animals. After tumour transplantation, mice were observed for up to 5 months for tumour appearance in the right flank. For karyotyping, short-term cultures were performed 3-15 days after dissociation of the grafted tumours.
Hypotonic shock (human plasma diluted 1:6 in distilled water), fixation by Carnoy with and without chloroform and R-banding were performed as previously described (Dutrillaux & Couturier, 1981 Table I , and Figure 2 gives one example (case N.G.) in which karyotypes were obtained from both primary tumour and xenograft. The most frequent imbalances observed were, in decreasing order of deficiencies: 10 (12/13), 9p (4/13), 16 and 22 (3/13), 14, 17q and 18 (1/13); and for gains 7 (9/13), lp and 20 (3/13). These results are in agreement with previously published data indicating the relationship between abnormal karyotypes and tumour progression.
Nucleotide metabolism in primary glial twnours Purine metabolism The mean activities of the ten enzymes involved in adenine metabolism, calculated from 16-30 cases, are shown in Figure 3 and compared with those measured in normal brain. As indicated by the large standard deviations, there were high inter-tumoral variations in activities of all the enzymes studied.
For the ten enzymes studied, mean activities compared with those measured in normal brain (100%) were very similar for ADK, MTAP and ADSL, lower for APRT (89%), AK (62%) and ADA (56%), and much lower for HPRT (35%), slightly higher for NP (126%) and much higher for AMPD (182%) and IMPDH (193%). However, differences were not statistically significant, except for HPRT (P = 0.04).
Pyrimidine metabolism The mean activities of the two enzymes (TK and TS) involved in pyrimidine metabolism, measured on 30 primary glial tumours, are shown in Figure  3 , and compared with activities in normal brain. Mean activities, especially for TS, were higher in tumours than in normal brain, however differences were not statistically significant. Figure 6 , and there were only slight variations from passage to passage for grafted tumours (data not shown). All enzyme activities were either similar to those measured in the corresponding primary gliomas or increased for ADSL (P=0.01), MTAP (P<0.01) and IMPDH (P<0.01).
Pyrimidine metabolism The two enzymes involved in pyrimidine metabolism had increased activities in xenografts, but the increase was more marked for TS. Large intertumoral variations for the two enzymes TK and TS were observed in grafted tumours, and also from passage to passage for the same tumour (data not shown). The increase between primary and grafted tumours was significant for both TK (P<0.01) and TS (P = 0.01), as shown in Figure 6 . Grafted tumours were characterised by a very low TK/TS ratio (0.2).
Comparison between enzyme activities and cytogenetic data As shown in Table I 
Disc-ssiom
The characteristic chromosomal anomalies occurring in human glial tumours are documented by the study of more than 100 cases (Rey et al., 1983 (Rey et al., , 1987a Bigner et al., 1986 Bigner et al., , 1988 Bigner et al., , 1990 Heim et al., 1989; Jenkins et al., 1989; Thiel et al., 1992 rearrangements generally lead to deletions of lq, 6q and 9p arms. In addition, chromosome 7 is very often in excess, whereas losses affect whole chromosomes 10 and less frequently 22 and the sex chromosomes (late replicating X or Y). In an attempt to elucidate the meaning of chromosome imblances in solid tumours, it was proposed that a relationship might exist with some metabolic modifications of cancer cells. For instance, the recurrent gains in endometrial adenocarcinoma affected chromosomes carrying genes for glycolysis (Couturier et al., 1988) , and in colorectal adenocarcinomas gains and losses affect chromosomes carrying genes encoding, respectively, the salvag and the de novo pathways of pyrimidine nucleotides (Dutrillaux & Mukris, 1986; Luccioni et al., 1988; Bardot et al., 1991) . In colorectal adenocarcinoma, this hypothesis was tested by the study of enzymes involved in pyrimidine metabolism in both primary and grafted tumours, and a good correlation between chromosome imbalances and enzyme activities was demonstrated, especially in grafted tumours which are devoid of human non-neoplastic cells. The metabolism of human gliomas remain largely unknown except for energy metabolism. The activities of many enzymes involved in glycolysis (Lowry et al., 1983; Marzatico et al., 1986 ) and the quantification of high-energy phosphate compounds (Lowry et al., 1977) suggest that gliomas have lower metabolic rates than normal brain tissue. Despite contradictory previous results (Lowry et al., 1983; Mangiardi & Yodice, 1990 , Pillwein et al., 1990 , the low levels of guanylate and adenylate pools in human gliomas were recently confirmed by Pillwein et al. (1990) . These authors also studid four enzymes involved in purine metabolism, three in the salvage pathway (HPRT, APRT, ADK) and one in the de novo synthesis (IMPDH). Only IMPDH activity was increased. Their results suggest a relatively low activity of purine metabolism in human gliobUastomas. Since cytogenetic data had demonstrated deficiencies of chromosomes 9, 10 and 22, carrying genes for MTAP and AK, ADK and ADSL respectively, it was of interest to study the same tumours by both cytogenetic and metabolic approaches. In gliomas there are large variations in the activities of enzymes involved in both purine and pyrimidine metabolism. Tlhis is in agreement with the well-documented heterogeneity of these neoplasms in terms of morphological and immunochemical properties and metabolic behaviour (Bigner et al., 1981; Paulus & Pfeiffer, 1989; Shapiro, 1986) . Despite these variations, our results show that glial tumours exhibit a characteristic profile of purine and pyrimidine metabolism compared with non-glial neoplasms (Figure 4 ). This study of 11 glial tumours with low malignancy revealed an abnormal and unbalanced karyotype in one case only. In the others, the karyotypes were normal (five cases) or no cell growth could be obtained (six cases). The assays performed on these samples show that the levels of most enzymes involved in purine and pyrimidine metabolism are similar in normal brain and in gliomas with low malignancy, as shown in Figure 5 . For ADA and HPRT, activities are lower in malignant cells. Among the 19 tumours with high malignancy, 12 had unbalaned karyotypes, one had normal chromosomes, one had only balanced rearrangements and no cell growth was obtained in five cases. The detected chromosome imbalances are in agreement with published data (Bigner et al., 1988 , Rey et al., 1983 , 1987 , except that we did not observe loss of sex chromosomes. For the two enzymes of pyrimidine synthesis, only TS activity is higher in tumours with high malignancy than in normal brain. It is noteworthy that the loss of chromosome segments occuring in tumours of high malignancy, by comparison with tumours of low grade, cormsponds to slightly lower activities.
Differences were too small to be statstically significant however, and the s.d. was large. The relationship between metabolic modifictions and chromosomal aberrations is far from direct and does not correspond to a gene dosage effect. It is even possible that the relative decrease in purine metabolism occurs before chromosome imblans, since it is observed at low malignancy, when most karyotypes are still normal.
Considering enzyme activities in purine metabolism, our results suggest a low rate of ATP synthesis, enzymes involved in the synthesis of adenylate pools such as ADK, APRT, AK, MTAP and ADSL being similar in gliomas and in normal brain. In contrast, enzymes involved in catabolism, such as NP and AMPD, are slightly more active in gliomas. Such findings are unexpected in malignant highly proliferative cells, which supposedly need a large ATP supply. However, activities of enzymes involved in pyrimidine metabolism are similar or higher in gliomas than in normal brain. This indicates that the tumour samples were not degraded and points to the importance of the relatively low pure metabolism.
The balance between de novo and salvage pathways also appears to be altered in gliomas. In normal brain, salvage pathway for adenylates is low (APRT, ADK and MTAP), whereas that for guanylates is high (HPRT). APRT, ADK and MTAP activities are low in gliomas, on average, suggesting a possible decrease in the activity of the adenylate salvage pathway. For guanylates, HPRT activity decreases, whereas that of IMPDH, involved in the de novo pathway, slightly increases, which is in agreement with previous data showing that IMPDH activity is an indicator of growth rate (Jackson & Weber, 1975) . These results also suggest a low activity of the salvage pathway, which contrasts with the hypothesis that an increased salvage/de novo pathway ratio characterises malignant cells (Natsumeda et al., 1984) . The same results are obtained for the thymidylate pathways, since the mean TK/TS ratio is decreased in tumours of high malignancy compared with normal brain.
The comparison between enzyme activities in primary and xenografted tumours deserves some comment (Figure 6) . A previous study on colorectal adenocarcinoma (Lefrangois et al., 1989) demonstrated the maintenance of chromosomal characteristics from fresh to xenografted tumours. The same observation was made in those cases in this study which could be studied before and after xenografting (not shown). As regards enzyme activities, similar characteristics could be found in fresh and xenografted colorectal cancers (Luccioni et al., 1988; Bardot et al., 1991) , although some differences existed. In this study, no significant changes were observed for five enzymes: ADK, AK, ADA, NP and AMPD. This suggests either that primary tumours are almost completely formed of malignant cells or that the presence of nonmalignant ceUs does not alter the overall activity of these enzymes. However, the activity of several other enzymes (ADSL, MTAP and IMPDH) involved in purine metabolsm, and TK, but more particularly TS, involved in pyrimidine metabolism, is increased in xenografts, which favours the second possibility. It is also noteworthy that, after xenografting, the imbalance between de novo and salvage pathways is amplified, de novo pathways increasing preferentially in both purine and pyrimidine metabolism. These differences could be partially explained by a higher tumour growth rate in nude mice, and by the fact that tumour transplantations were conducted on the right flank of the mice and not intracerebrally.
In conclusion, cytogenetic data are well correlated with tumour stage, low-grade malignancies having normal or almost normal karyotypes, whereas high-grade malignancies have more anomalies, resulting in imbalances, principally chromosome losses or deletions. These deletions affect a number of genes involved in adenine metabolism, which is found to be of low activity. It is noteworthy that in highly malignant tumours, which are proliferative, the rate of adenine metabolism is not increased, in spite of their need of DNA precursors. This could result in a low ATP formation, which is in agreement with published data (Pillwein et al., 1990 
